[Federal Register Volume 67, Number 216 (Thursday, November 7, 2002)]
[Notices]
[Page 67870]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-28314]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 21, 2002, Aldrich 
Chemical Company Inc., dba Isotec, 3858 Benner Road, Miamisburg, Ohio 
45342-4304, made application to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
N-Ethylamphetamine (1475)..................  I
N,N-Dimethylamphetamine (1480).............  I
Aminorex (1585)............................  I
Gamma hydroxybutyric acid (2010)...........  I
Methaqualone (2565)........................  I
Lysergic acid dethylamide (7315)...........  I
Tetrahydrocannabinols (7370)...............  I
Mescaline (7381)...........................  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxy-methamphetamine (7405)..  I
4-Methoxyamphetamine (7411)................  I
Psilocybin (7437)..........................  I
Psilocyn (7438)............................  I
N-Ethyl-1-phenylcyclohexylamine (7455).....  I
Dihydromorphine (9145).....................  I
Normorphine (9313).........................  I
Acetylmethadol (9601)......................  I
Alphacetylmethadol Except Levo-              I
 Alphacetylmethadol (9603).
Normethadone (9635)........................  I
3-Methylfentanyl (9813)....................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
Phenylacetone (8501).......................  II
1-Piperidinocyclohexane-carbonitrile (8603)  II
Codeine (9050).............................  II
Dihydrocodeine (9120)......................  II
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Benzoylecgonine (9180).....................  II
Ethylmorphine (9190).......................  II
Hydrocodone (9193).........................  II
Isomethadone (9226)........................  II
Meperidine (9230)..........................  II
Meperidine intermediate-A (9232)...........  II
Merperidine intermediate-B (9233)..........  II
Methadone (9250)...........................  II
Methadone intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Levo-Alphacetylmethadol (9648).............  II
Oxymorphone (9652).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances to produce standards for analytical laboratories.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than January 6, 2003.

    Dated: October 25, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-28314 Filed 11-6-02; 8:45 am]
BILLING CODE 4410-09-M